AlphaMark Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,135
| Closed | – | – | 849 |
|
|
2024
Q2 | $0 | Hold |
2,135
| – | – | ﹤0.01% | 856 |
|
|
2024
Q1 | $0 | Hold |
2,135
| – | – | ﹤0.01% | 838 |
|
|
2023
Q4 | $0 | Sell |
2,135
-1,000
| -32% | – | ﹤0.01% | 820 |
|
|
2023
Q3 | $0 | Hold |
3,135
| – | – | ﹤0.01% | 786 |
|
|
2023
Q2 | $1K | Hold |
3,135
| – | – | ﹤0.01% | 608 |
|
|
2023
Q1 | $1K | Hold |
3,135
| – | – | ﹤0.01% | 603 |
|
|
2022
Q4 | $3K | Sell |
3,135
-865
| -22% | -$828 | ﹤0.01% | 504 |
|
|
2022
Q3 | $6K | Hold |
4,000
| – | – | ﹤0.01% | 491 |
|
|
2022
Q2 | $8K | Hold |
4,000
| – | – | ﹤0.01% | 427 |
|
|
2022
Q1 | $9K | Buy |
4,000
+2,500
| +167% | +$5.63K | ﹤0.01% | 421 |
|
|
2021
Q4 | $7K | Buy |
+1,500
| New | +$7K | ﹤0.01% | 434 |
|